Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Edelman

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
The Annals of Thoracic Surgery|May 1, 1996
Multimodality therapy in stage III non-small cell lung cancerM J Edelman, D R Gandara, M Roach, et al.
Oncology (Williston Park, N.Y.)|August 29, 2000
Gemcitabine/carboplatin combination regimens: importance of dose scheduleD R Gandara, D H Lau, P N Lara, et al.
Investigational New Drugs|December 16, 1998
Phase II trial of pyrazine diazohydroxide in androgen-independent prostate cancerM J Edelman, F J Meyers, T Grennan, et al.
Oncology (Williston Park, N.Y.)|April 17, 2001
Gemcitabine in combination with new platinum compounds: an updateD R Gandara, M J Edelman, P N Lara, et al.
Urology|February 1, 1996
The potential for reintroduction of tumor cells during intraoperative blood salvage: reduction of risk with use of the RC-400 leukocyte depletion filterM J Edelman, P Potter, K G Mahaffey, et al.
Seminars in Oncology|April 14, 1999
Gemcitabine and carboplatin in combination: an update of phase I and phase II studies in non-small cell lung cancerC J Langer, D R Gandara, P Calvert, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Phase II trial of edatrexate plus carboplatin in metastatic non-small-cell lung cancer: a Southwest Oncology Group studyD R Gandara, M J Edelman, J J Crowley, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 18, 1998
Consensus proposal for 5HT3 antagonists in the prevention of acute emesis related to highly emetogenic chemotherapy. Dose, schedule, and route of administrationD R Gandara, F Roila, D Warr, et al.
Cancer|July 10, 2001
Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: carboplatin and gemcitabine followed by paclitaxelM J Edelman, D R Gandara, D H Lau, et al.
Urology|March 29, 2000
Phase I/II study of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma: a well-tolerated regimen with activity independent of p53 mutationM J Edelman, F J Meyers, T R Miller, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
The Annals of Thoracic Surgery|May 1, 1996
Multimodality therapy in stage III non-small cell lung cancerM J Edelman, D R Gandara, M Roach, et al.
Oncology (Williston Park, N.Y.)|August 29, 2000
Gemcitabine/carboplatin combination regimens: importance of dose scheduleD R Gandara, D H Lau, P N Lara, et al.
Investigational New Drugs|December 16, 1998
Phase II trial of pyrazine diazohydroxide in androgen-independent prostate cancerM J Edelman, F J Meyers, T Grennan, et al.
Oncology (Williston Park, N.Y.)|April 17, 2001
Gemcitabine in combination with new platinum compounds: an updateD R Gandara, M J Edelman, P N Lara, et al.
Urology|February 1, 1996
The potential for reintroduction of tumor cells during intraoperative blood salvage: reduction of risk with use of the RC-400 leukocyte depletion filterM J Edelman, P Potter, K G Mahaffey, et al.
Seminars in Oncology|April 14, 1999
Gemcitabine and carboplatin in combination: an update of phase I and phase II studies in non-small cell lung cancerC J Langer, D R Gandara, P Calvert, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Phase II trial of edatrexate plus carboplatin in metastatic non-small-cell lung cancer: a Southwest Oncology Group studyD R Gandara, M J Edelman, J J Crowley, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 18, 1998
Consensus proposal for 5HT3 antagonists in the prevention of acute emesis related to highly emetogenic chemotherapy. Dose, schedule, and route of administrationD R Gandara, F Roila, D Warr, et al.
Cancer|July 10, 2001
Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: carboplatin and gemcitabine followed by paclitaxelM J Edelman, D R Gandara, D H Lau, et al.
Urology|March 29, 2000
Phase I/II study of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma: a well-tolerated regimen with activity independent of p53 mutationM J Edelman, F J Meyers, T R Miller, et al.
Pageof 5